OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Target-Based Radiosensitization Strategies: Concepts and Companion Animal Model Outlook
Matthew R. Berry, Timothy M. Fan
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 9
Matthew R. Berry, Timothy M. Fan
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 9
Showing 9 citing articles:
The use of nanomaterials in advancing photodynamic therapy (PDT) for deep-seated tumors and synergy with radiotherapy
Deepak Dinakaran, Brian C. Wilson
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 24
Deepak Dinakaran, Brian C. Wilson
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 24
BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer
Sushmitha Sriramulu, Shivani Thoidingjam, Wei‐Min Chen, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Sushmitha Sriramulu, Shivani Thoidingjam, Wei‐Min Chen, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Molecular targets that sensitize cancer to radiation killing: From the bench to the bedside
Sushmitha Sriramulu, Shivani Thoidingjam, Stephen L. Brown, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114126-114126
Open Access | Times Cited: 17
Sushmitha Sriramulu, Shivani Thoidingjam, Stephen L. Brown, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114126-114126
Open Access | Times Cited: 17
Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer
Charnay Cunningham, Julie Bolcaen, Alessandra Bisio, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 219-219
Open Access | Times Cited: 4
Charnay Cunningham, Julie Bolcaen, Alessandra Bisio, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 219-219
Open Access | Times Cited: 4
BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer
Sushmitha Sriramulu, Shivani Thoidingjam, Wei‐Min Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Sushmitha Sriramulu, Shivani Thoidingjam, Wei‐Min Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Glucose oxidase and MnO2 functionalized liposome for catalytic radiosensitization enhanced synergistic breast cancer therapy
Lihua Shao, D. Liu, Xuexue Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117402-117402
Open Access | Times Cited: 1
Lihua Shao, D. Liu, Xuexue Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117402-117402
Open Access | Times Cited: 1
Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy
Leon Emanuel Schnöller, Valérie Albrecht, Nikko Brix, et al.
Radiation Oncology (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Leon Emanuel Schnöller, Valérie Albrecht, Nikko Brix, et al.
Radiation Oncology (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Radiotherapeutic Treatment of an Epidermoid Tumor in a Patient With Zanubrutinib-Treated Mantle Cell Lymphoma: The First Report of Concomitant Treatment
François Fabi, Louis-Philippe Grenier, Robert Delage, et al.
Cureus (2024)
Open Access
François Fabi, Louis-Philippe Grenier, Robert Delage, et al.
Cureus (2024)
Open Access
Drugs that modulate resistance to antitumor agents
Carmen Avendaño, J. Carlos Menéndez
Elsevier eBooks (2023), pp. 901-963
Closed Access
Carmen Avendaño, J. Carlos Menéndez
Elsevier eBooks (2023), pp. 901-963
Closed Access
